Cite
HARVARD Citation
Crunelle, C. et al. (n.d.). Cannabinoid‐1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction biology. pp. 908-911. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Crunelle, C. et al. (n.d.). Cannabinoid‐1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction biology. pp. 908-911. [Online].